China, one of the largest economies in the world, hosts the 15th edition of the Immersion in Innovation Ecosystems Program and receives the director of the Brazilian Enterprise for Research and Industrial Innovation (EMBRAPII), Jorge Guimarães. The program, which runs until April 26, will allow Brazilian managers, entrepreneurs and researchers to learn about China's strategy to promote innovation in the country. The objective is to favor the generation of new businesses, as well as the connection of productive chains, promoting cooperation between companies and institutions of the two countries.

In the program are planned visits in three different cities: Beijing, a benchmark in technology with more than seven thousand startups; Shanghai, considered the capital of fintechs (startups focused on finance); and Hangzhou, the world's leading e-commerce city with more than a third of all China's e-commerce websites, including the giant Alibaba. Also scheduled is a lecture with technicians from Torch Center, the office responsible for formulating China's science, technology and innovation strategy.

The Chinese government collaborates with training, capital allocation for research and development in universities and centers focused on technology transfer, as well as granting tax incentives to attract foreign capital. Only in 2018 did it announce a $ 2.1 billion investment in artificial intelligence.

Immersion is an initiative of MEI (Business Mobilization for Innovation) and carried out by CNI (National Confederation of Industry). The mission script is organized in partnership with the Ministry of Foreign Affairs, Apex-Brazil and StartSe. Since the launch of the program in 2016, 14 editions have been held both abroad (United States, Germany, Sweden, Netherlands, Israel, Italy, Switzerland) and Brazil (341 executives from 194 different organizations participated).

About EMBRAPII

EMBRAPII, an organization linked to the Ministry of Science, Technology, Innovation and Communications, acts through cooperation with public and private scientific and technological research institutions, focusing on business demands and targeting risk sharing in the pre- competitiveness of innovation. Currently, there are 42 units accredited by the country.

The financing of the institution follows the following general rule: EMBRAPII can invest up to 1/3 of the expenses of the Units with PD & I projects (non-reimbursable resources), while the rest is divided between the partner company and the Unit. By sharing project risks with the entities (by dividing project costs), the industry is encouraged to innovate more and with greater technological intensity, in order to boost the competitive strength of companies in the domestic and international market.